Seller record · Telehealth service

Reset Solutions

Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named on the home, GLP-1 or Medicare pages or in the privacy policy, and the Medicare page says brand-name medication comes from the patient's regular pharmacy. 2 more criteria also fail; see the table below.

At a glance

Reset SolutionsTelehealth service

5/8criteria passed
Price
A $99 monthly program, with GLP-1 medication from around $70 a month
Sells
semaglutide, tirzepatide, Wegovy, and 4 more
FDA letters
None on file
Visit Reset SolutionsSee all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A physician-led weight loss clinic in Shenandoah, Texas that prescribes semaglutide and tirzepatide after a telehealth consultation, with in-person kickoff visits, coaching, 3D body composition scans and metabolic testing for a monthly program fee. It also enrolls Medicare patients in the federal GLP-1 bridge program.

Operating entity Reset Medical Practice P.A.

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSReset Solutions' GLP-1 weight loss page; Reset Solutions' website
S2Prescription gatingPASSReset Solutions' GLP-1 weight loss page
S3Pharmacy identificationFAILReset Solutions' GLP-1 weight loss page; Reset Solutions' medicare page; Reset Solutions' privacy page
S4Compounding disclosureFAILReset Solutions' GLP-1 weight loss page; Reset Solutions' website
S5Analytical documentationFAILReset Solutions' website; Reset Solutions' GLP-1 weight loss page; Reset Solutions' medicare page
S6Business addressPASSReset Solutions' website; Reset Solutions' privacy page
S7Price disclosurePASSReset Solutions' GLP-1 weight loss page; Reset Solutions' medicare page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSThe practice's physicians prescribe GLP-1 medication after a telehealth consultation with its doctor, only when it is medically appropriate, and the local team adjusts the dose over time.Source: Reset Solutions' GLP-1 weight loss page; Reset Solutions' website.
S2PASSThe program starts with a telehealth consultation with the doctor, who prescribes only if the patient is a candidate, and patients who are not candidates are fully refunded. No medication is sold before that consultation.Source: Reset Solutions' GLP-1 weight loss page.
S3FAILNo filling pharmacy is named on the home, GLP-1 or Medicare pages or in the privacy policy, and the Medicare page says brand-name medication comes from the patient's regular pharmacy.Source: Reset Solutions' GLP-1 weight loss page; Reset Solutions' medicare page; Reset Solutions' privacy page.
S4FAILNo page says whether the semaglutide and tirzepatide are compounded or states that compounded products are not FDA-approved. The GLP-1 page describes the medications by the brand names Wegovy, Ozempic, Mounjaro and Zepbound while pricing them from around $70 a month.Source: Reset Solutions' GLP-1 weight loss page; Reset Solutions' website.
S5FAILNo certificate of analysis or lot document is published on the home page, the GLP-1 page or the Medicare page.Source: Reset Solutions' website; Reset Solutions' GLP-1 weight loss page; Reset Solutions' medicare page.
S6PASS150 Pine Forest Drive Suite 603, Shenandoah, TX 77384, printed in the footer of every page. The privacy policy names Reset Medical Practice P.A., doing business as Reset Solutions, and Reset Medical LLC, and Texas law.Source: Reset Solutions' website; Reset Solutions' privacy page.
S7PASSThe program costs $99 a month and covers medical visits, coaching, 3D body composition scans, metabolic testing and the app, with no long-term contract. Medication is priced separately from around $70 a month. Under the Medicare GLP-1 bridge program, Wegovy, Zepbound and Foundayo cost qualifying patients $50 a month, or $149 a month with the program.Source: Reset Solutions' GLP-1 weight loss page; Reset Solutions' medicare page.
S8PASSNo FDA warning letter names Reset Solutions or Reset Medical Practice P.A., and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: semaglutide, tirzepatide, Wegovy, Zepbound, Foundayo, 3D body composition scans, metabolic (RMR) testing.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatide

Visit Reset Solutions

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.